Literature DB >> 10578046

Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.

T Irimura1, K Denda, S i Iida, H Takeuchi, K Kato.   

Abstract

Mucins are major epithelial luminal surface proteins and function as a physical and biological barrier protecting mucous epithelia. Diverse glycosylation of mucins potentially provides a basis for tissue-specific interaction with the milieu. When mucins are associated with malignant epithelial cells, they not only protect these cells from a host environment during metastatic dissemination but also generate immunogenic epitopes which are used by the host in the detection and immunological elimination of carcinoma cells potentially depending upon their status of glycosylation. Diverse mucin structures are generated by the combination of different core peptides, of which 10 have been reported so far, multiple types of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases (pp-GalNAc-Ts), and the consequences of stepwise glycosylation events. For example, the mucin 1 (MUC1) associated with malignant cells was previously believed to exhibit unique features with a lower percentage of threonine and serine residues attached to N-acetylgalactosamine and/or without extension through core 2 structures. Some of MUC1-specific monoclonal antibodies and cytotoxic lymphocytes recognize the peptide sequences PDTR within the tandem repeat portion exposed by decreased degree of glycosylation. The specific arrangement of N-acetylgalactosamine residues is shown to be generated by a combination of pp-GalNAc-Ts with different specificities. The role of core 2 branching is somewhat confusing because well-known carcinoma-associated carbohydrate epitopes such as sialyl-Le(X), sialyl-Le(a), Le(Y), and others are often expressed when O-glycans are extended through core 2 branching. The other series of well-known carcinoma-associated carbohydrate structures are truncated O-glycans, conventionally called Tn and sialyl-Tn antigens. Interestingly, these are often found to be aligned on core polypeptides, resulting in three or more consecutive truncated O-glycans. MUC2 and other mucins, but not MUC1, have unique tandem repeats containing three or more consecutive serine or threonine residues, which potentially serve as a scaffold for trimeric Tn and sialyl-Tn epitopes. We recently found, using the MUC2 tandem repeat, that trimeric Tn is a high-affinity receptor for a calcium-type lectin expressed on the surface of histiocytic macrophages. The biosynthesis of trimeric Tn was strictly regulated by the acceptor specificity of pp-GalNAc-Ts. These results strongly suggest that variation in both glycan structures and distribution of glycans on the core polypeptides give mucins unique and diverse biological functions that play essential roles in carcinoma-host and other cellular interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10578046     DOI: 10.1093/oxfordjournals.jbchem.a022565

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  13 in total

1.  Influence of sialic acid removal on MUC1 antigenic reactivity in head and neck carcinoma.

Authors:  María V Croce; Martín E Rabassa; Adrián Pereyra; Amada Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

Review 2.  Lewis x is highly expressed in normal tissues: a comparative immunohistochemical study and literature revision.

Authors:  María V Croce; Marina Isla-Larrain; Martín E Rabassa; Sandra Demichelis; Andrea G Colussi; Marina Crespo; Ezequiel Lacunza; Amada Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

3.  Hypervariability of the membrane-associated mucin and cancer marker MUC1.

Authors:  Joanna C Fowler; Ana S Teixeira; Lynne E Vinall; Dallas M Swallow
Journal:  Hum Genet       Date:  2003-08-27       Impact factor: 4.132

4.  Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice.

Authors:  V Kudryashov; P W Glunz; L J Williams; S Hintermann; S J Danishefsky; K O Lloyd
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis.

Authors:  Akira Konno; Yutaka Hoshino; Shinya Terashima; Ryoichi Motoki; Takanori Kawaguchi
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems.

Authors:  K Denda-Nagai; K Fujita; M Fujime; S Nakatsugawa; T Ishigaki; T Irimura
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1.

Authors:  Atsushi Matsuda; Michiyo Higashi; Tomomi Nakagawa; Seiya Yokoyama; Atsushi Kuno; Suguru Yonezawa; Hisashi Narimatsu
Journal:  Lab Invest       Date:  2017-06-05       Impact factor: 5.662

8.  MUC1 expressing tumor growth was retarded after human mucin 1 (MUC1) plasmid DNA immunization.

Authors:  Hye-Youn Son; Hwan-Kyu Jeong; Vasso Apostolopoulos; Chul-Woo Kim
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

Review 9.  MUC1 in carcinoma-host interactions.

Authors:  K Denda-Nagai; T Irimura
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 3.009

10.  The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma.

Authors:  Yang Ling; Jing Zhu; Lu Gao; Yongping Liu; Changtai Zhu; Rong Li; Lixin Wei; Changsong Zhang
Journal:  BMC Med Genet       Date:  2013-01-25       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.